Using flow cytometry we recently confirmed the importance of IL-6-mediated STAT3 activation in CD4+ T cells (in contrast to other circulating cytokines and leukocytes) as an early event in the clinical phase of RA, and suggested its potential value as a diagnostic biomarker [8]. This evidence concerns the gene IL6 and rheumatoid arthritis.